213 related articles for article (PubMed ID: 6090838)
21. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
22. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
Hashimoto S; Shibata S; Kobayashi B
Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
[TBL] [Abstract][Full Text] [Related]
23. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
Haslam RJ; Rosson GM
Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
[No Abstract] [Full Text] [Related]
24. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
25. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
[TBL] [Abstract][Full Text] [Related]
26. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels.
Bourdillat B; Delautier D; Labat C; Benveniste J; Potier P; Brink C
Eur J Pharmacol; 1988 Feb; 147(1):1-6. PubMed ID: 2836213
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
[TBL] [Abstract][Full Text] [Related]
28. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
[TBL] [Abstract][Full Text] [Related]
29. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
[TBL] [Abstract][Full Text] [Related]
30. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
[TBL] [Abstract][Full Text] [Related]
31. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
32. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological properties of platelet strips.
Yamakado T; Nishikawa M; Azuma H; Hidaka H
Eur J Pharmacol; 1983 Aug; 91(4):441-7. PubMed ID: 6684577
[TBL] [Abstract][Full Text] [Related]
34. Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.
Vigdahl RL; Marquis NR; Tavormina PA
Biochem Biophys Res Commun; 1969 Oct; 37(3):409-15. PubMed ID: 4310667
[TBL] [Abstract][Full Text] [Related]
35. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
36. Refractoriness of diabetic platelets to inhibitory prostaglandins.
Lagarde M; Berciaud P; Burtin M; Dechavanne M
Prostaglandins Med; 1981 Oct; 7(4):341-7. PubMed ID: 6273957
[TBL] [Abstract][Full Text] [Related]
37. Ageing and the alpha 2-adrenergic system of the platelet.
Davis PB; Silski C
Clin Sci (Lond); 1987 Nov; 73(5):507-13. PubMed ID: 2824117
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
Azuma H; Takashima Y; Ishikawa M; Yamakado T
Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194
[TBL] [Abstract][Full Text] [Related]
39. Effects of dibutyryl cyclic adenosinemonophosphate and prostaglandin E1 on platelet aggregation and shape changes.
Wang TY; Hussey CV; Garancis JC
Am J Clin Pathol; 1977 Apr; 67(4):362-7. PubMed ID: 192067
[TBL] [Abstract][Full Text] [Related]
40. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
